The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
NCT05325424 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-05-30
Summary
In this study, the investigators compared the improvement of liver reserve function related indicators in patients with liver cirrhosis after laparoscopic splenectomy. To determine whether surgical treatment can help enhance postoperative liver reserve function and improve patient prognosis.
Conditions
- Cirrhosis, Liver
- Splenectomy; Status
Interventions
- PROCEDURE
-
Laparoscopic splenectomy
The laparoscopic splenectomy was performed by the same surgical team.
Sponsors & Collaborators
-
Northern Jiangsu People's Hospital
lead OTHER
Principal Investigators
-
Guo-Qing Jiang, MD · Clinical Medical College of Yangzhou University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- China
Study Locations
More Related Trials
-
Fecal Microbiota Transplantation for Decompensated Cirrhosis
NCT03014505 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis
NCT01499459 ·Status: UNKNOWN ·Phase: NA
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01483248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis
NCT05121870 ·Status: UNKNOWN ·Phase: PHASE2
-
Expanding Donor Pool for Live Donor Liver Transplantation: Utilization of Donors With NASH After Optimization
NCT04571957 ·Status: COMPLETED
-
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
NCT06773221 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells
NCT05155657 ·Status: UNKNOWN ·Phase: PHASE1
-
Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis
NCT03209986 ·Status: UNKNOWN ·Phase: NA
-
Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study
NCT05036031 ·Status: UNKNOWN
-
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation
NCT05256979 ·Status: ACTIVE_NOT_RECRUITING
-
Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
NCT05106972 ·Status: RECRUITING ·Phase: NA
-
Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients
NCT01718587 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
Ketogenic Diet in MASLD-related cACLD
NCT06537466 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis
NCT06296095 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis.
NCT03995251 ·Status: UNKNOWN ·Phase: NA
-
Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis
NCT05331872 ·Status: COMPLETED ·Phase: PHASE1
-
Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
NCT06321211 ·Status: COMPLETED
-
The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis
NCT01741090 ·Status: UNKNOWN ·Phase: PHASE2
-
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
NCT05966025 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
NCT06569524 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
NCT02030977 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Mesenchymal Stem Cell Transplantation in Decompensated Cirrhosis
NCT00476060 ·Status: COMPLETED ·Phase: PHASE2
-
YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation
NCT00450398 ·Status: UNKNOWN ·Phase: PHASE2